Intellectual Property India Publishes Patent Application for 'Bispecific Chimeric Antigen Receptors Targeting CD20 And BCMA' Filed by Abelzeta Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517068354 A) filed by Abelzeta Inc., Rockville, U.S.A., on July 17, for 'bispecific chimeric antigen receptors targeting cd20 and bcma.'

Inventor(s) include Yao, Yihong; Huang, Jiaqi; Zhu, Shigui; Yao, Xin; Luo, Xiaobing; and Wei, Yutian.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides bispecific chimeric antigen receptors targeting CD20 and BCMA. The CAR may comprise an scFv targeting CD20 and an scFv targeting BCMA, a hinge region, a transmembrane domain, a co-stimulatory region, and a cytoplasmic signaling domain. The chimeric antigen receptors can be used to treat autoimmune disorders or cancer."

The patent application was internationally filed on Mar. 29, 2024, under International application No.PCT/US2024/022317.

Disclaimer: Curated by HT Syndication.